Limited Time Offer
Get $1000 towards your
first investment
Start investing in private markets with Linqto – your access to disruptive startups and pre-IPO companies.
*Terms and conditions apply. See details
CTRL-labs, founded in 2015 and based in New York, is a biotechnology company specializing in neural interface technology. The company develops non-invasive wearable devices that enable computers to interpret human thoughts and movements, primarily serving sectors requiring advanced human-computer interaction capabilities. CTRL-labs has made significant strides in its field, attracting attention from major tech players.
In September 2019, CTRL-labs was acquired by Meta (formerly Facebook) at a valuation estimated between $500 million and $1 billion. This acquisition marked a significant milestone for the company, highlighting the potential value of its innovative technology in the rapidly evolving field of human-computer interaction.
Given the company's acquisition by Meta, it is unlikely that CTRL-labs will pursue an initial public offering (IPO) as an independent entity. The integration into Meta's ecosystem may have altered the company's trajectory, potentially focusing its efforts on developing technology for Meta's projects rather than seeking public investment.
It's important to note that we do not have any current information or reports regarding CTRL-labs' IPO prospects. As the company is now part of Meta, any future public offering would likely be tied to Meta's overall corporate strategy rather than CTRL-labs as a standalone entity. Investors interested in gaining exposure to CTRL-labs' technology may need to consider Meta's stock as a proxy.
Get $1000 towards your
first investment
*Terms and conditions apply. See details
While CTRL-labs' IPO prospects remain uncertain, investors eager to gain exposure to innovative companies in the brain-computer interface space don't have to wait. At Linqto, we offer members access to interests in promising pre-IPO private companies, including potential leaders in cutting-edge technology sectors. Our platform allows you to diversify your portfolio with lower minimum investments, potentially benefiting from the growth of emerging industry pioneers like CTRL-labs before they go public.
*These comments should not be interpreted to mean that the company is formally pursuing or foregoing an IPO. The information provided above is based on current online discussions and is not intended as investment advice. Linqto does not endorse or guarantee the accuracy of this information, and we strongly recommend conducting your own research or consulting with a professional advisor before making any investment decisions. Linqto cannot be held liable for any investment outcomes resulting from the use of this information.
